Nonprofit BBB National Programs launched an investigation into GLP-1 related advertising by Ryze Superfoods, which sells mushroom-based coffee and matcha, at which point the company agreed to stop advertising products as appetite suppressing in September 2025
[DOI] [PMC free article] [PubMed] [Google Scholar] 15.Evaluating appetite/satiety hormones and eating behaviours as predictors of weight loss maintenance with GLP-1RA therapy in adolescents with severe obesity
Back WHO (1 March 2024) 'Obesity and overweight', WHO News
Alcohol also increases blood sugar variability and can trigger insulin resistance, which works against the glucose-stabilizing effects of GLP-1 therapy
Key factors influencing vomiting risk include: Dose escalation speed rapid increases in dose are associated with higher symptom rates Individual susceptibility some patients are inherently more prone to gastrointestinal side effects Concurrent medications other drugs affecting gastric motility may compound effects Dietary habits large, high-fat meals can exacerbate symptoms It is important to note that whilst mild, occasional vomiting can be an expected side effect, severe or persistent vomiting is not normal and may indicate complications requiring medical assessment